Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Lab Physicians ; 13(1): 6-13, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-34054235

RESUMEN

Background The stability of biological samples is vital for reliable measurements of biomarkers in large-scale survey settings, which may be affected by freeze-thaw procedures. We examined the effect of a single freeze-thaw cycle on 13 nutritional, noncommunicable diseases (NCD), and inflammatory bioanalytes in serum samples. Method Blood samples were collected from 70 subjects centrifuged after 30 minutes and aliquoted immediately. After a baseline analysis of the analytes, the samples were stored at - 70°C for 1 month and reanalyzed for all the parameters. Mean percentage differences between baseline (fresh blood) and freeze-thaw concentrations were calculated using paired sample t -tests and evaluated according to total allowable error (TEa) limits (desirable bias). Results Freeze-thaw concentrations differed significantly ( p < 0.05) from baseline concentrations for soluble transferrin receptor (sTfR) (- 5.49%), vitamin D (- 12.51%), vitamin B12 (- 3.74%), plasma glucose (1.93%), C-reactive protein (CRP) (3.45%), high-density lipoprotein (HDL) (7.98%), and cholesterol (9.76%), but they were within respective TEa limits. Low-density lipoprotein (LDL) (- 0.67%), creatinine (0.94%), albumin (0.87%), total protein (1.00%), ferritin (- 0.58%), and triglycerides (TAG) (2.82%) concentrations remained stable following the freeze-thaw cycle. In conclusion, single freeze-thaw cycle of the biomarkers in serum/plasma samples after storage at - 70°C for 1 month had minimal effect on stability of the studied analytes, and the changes in concentration were within acceptable limit for all analytes.

3.
Indian J Community Med ; 38(3): 175-9, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24019604

RESUMEN

BACKGROUND AND OBJECTIVES: Hypertension is one of the most common diseases world-wide and the prevalence in school-aged children appears to be increasing perhaps as a result of increased prevalence of obesity. Thus, the present study was planned to establish an association between body mass index (BMI) and waist circumference (WC) with hypertension amongst school children in the age group of 5-16 years belonging to lower income group (LIG) and middle income group (MIG) in National Capital Territory of Delhi. SUBJECTS AND METHODS: Population proportionate to size methodology was adopted to select 30 clusters/schools in each LIG and MIG category. About 170 children from each school were selected randomly with the help of random number tables. Anthropometric measurements of weight, height and WC and blood pressure measurements were taken by using the standard methodology. RESULTS AND INTERPRETATION: t0 he prevalence of high systolic blood pressure (SBP) in LIG and MIG school population was 3.8 and 4.4% with high WC and BMI are more likely to have hypertension. SUBJECTS AND METHODS: Population proportionate to size methodology was adopted to select 30 clusters/schools in each LIG and MIG category. About 170 children from each school were selected randomly with the help of random number tables. Anthropometric measurements of weight, height and WC and blood pressure measurements were taken by using the standard methodology. RESULTS AND INTERPRETATION: t0 he prevalence of high systolic blood pressure (SBP) in LIG and MIG school population was 3.8 and 4.4% with high WC and BMI are more likely to have hypertension.

5.
Indian J Orthop ; 41(1): 4-10, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21124675

RESUMEN

Evidence based medicine is the practice of solving the clinical problems in one's practice by judicious and systematic use of the medical literature. This includes framing questions rightly and searching the right kind of literature. Thereafter, the available evidence needs to be evaluated for the validity, strength and effect size. Finally, the results are examined for applicability to the current problem which requires a detailed knowledge of the clinical setting, patient profile and the issues related to cost and harm. The present communication deals with these issues in a step-wise manner in order to stimulate readers to practise this important art.

6.
Public Health Nutr ; 9(7): 904-20, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17010257

RESUMEN

OBJECTIVE: To evaluate the effect of iron supplementation on physical growth in children through a systematic review of randomised controlled trials (RCTs). DATA SOURCES: Electronic databases, personal files, and hand search of reviews, bibliographies of books, abstracts and proceedings of international conferences. REVIEW METHODS: RCTs evaluating change in anthropometry with interventions that included oral or parenteral iron supplementation, or iron-fortified formula milk or cereals, were analysed. RESULTS: Twenty-five trials (26 cohorts) had relevant information. There was no evidence of publication bias. The pooled estimates (random effects model) did not document a statistically significant (P>0.05) positive effect of iron supplementation on any anthropometric variable (weight-for-age, weight-for-height, height-for-age, mid upper-arm circumference, skinfold thickness, head circumference). Significant heterogeneity was evident, and its predictors included greater weight-for-age in supplemented children in malaria hyperendemic regions and greater weight-for-height for children above 5 years of age, but a negative effect on linear growth in developed countries and with supplementation for 6 months or longer. CONCLUSIONS: This review did not document a positive effect of iron supplementation on the physical growth of children. The identified predictors of heterogeneity should be considered as exploratory and requiring confirmation, not conclusive.


Asunto(s)
Anemia Ferropénica/fisiopatología , Estatura , Crecimiento/efectos de los fármacos , Hierro de la Dieta/administración & dosificación , Adolescente , Anemia Ferropénica/tratamiento farmacológico , Estatura/efectos de los fármacos , Estatura/fisiología , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Niño , Desarrollo Infantil/efectos de los fármacos , Desarrollo Infantil/fisiología , Preescolar , Suplementos Dietéticos , Femenino , Alimentos Fortificados , Humanos , Lactante , Hierro de la Dieta/efectos adversos , Hierro de la Dieta/uso terapéutico , Masculino , Ensayos Clínicos Controlados Aleatorios como Asunto , Grosor de los Pliegues Cutáneos , Factores de Tiempo , Resultado del Tratamiento
7.
Public Health Nutr ; 8(2): 117-32, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15877905

RESUMEN

OBJECTIVE: To evaluate the effect of iron supplementation on mental and motor development in children through a systematic review of randomised controlled trials (RCTs). DATA SOURCES: Electronic databases, personal files, hand search of reviews, bibliographies of books, abstracts and proceedings of international conferences. REVIEW METHODS: RCTs with interventions that included oral or parenteral iron supplementation, fortified formula milk or cereals were evaluated. The outcomes studied were mental and motor development scores and various individual development tests employed, including Bayley mental and psychomotor development indices and intelligence quotient. RESULTS: The pooled estimate (random effects model) of mental development score standardised mean difference (SMD) was 0.30 (95% confidence interval (CI) 0.15 to 0.46, P<0.001; P<0.001 for heterogeneity). Initial anaemia and iron-deficiency anaemia were significant explanatory variables for heterogeneity. The pooled estimate of Bayley Mental Development Index (weighted mean difference) in younger children (<27 months old) was 0.95 (95% CI -0.56 to 2.46, P=0.22; P=0.016 for heterogeneity). For intelligence quotient scores (> or =8 years age), the pooled SMD was 0.41 (95% CI 0.20 to 0.62, P<0.001; P=0.07 for heterogeneity). There was no effect of iron supplementation on motor development score (SMD 0.09, 95% CI -0.08 to 0.26, P=0.28; P=0.028 for heterogeneity). CONCLUSIONS: Iron supplementation improves mental development score modestly. This effect is particularly apparent for intelligence tests above 7 years of age and in initially anaemic or iron-deficient anaemic subjects. There is no convincing evidence that iron treatment has an effect on mental development in children below 27 months of age or on motor development.


Asunto(s)
Anemia Ferropénica/tratamiento farmacológico , Desarrollo Infantil/efectos de los fármacos , Cognición/efectos de los fármacos , Hierro/uso terapéutico , Desempeño Psicomotor/efectos de los fármacos , Adolescente , Anemia Ferropénica/complicaciones , Niño , Preescolar , Suplementos Dietéticos , Femenino , Humanos , Lactante , Recién Nacido , Hierro/administración & dosificación , Masculino , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Tiempo , Resultado del Tratamiento
8.
BMJ ; 317(7173): 1664, 1998 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-9848928
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA